Get the Stockscreener App
11.52
0.17%
0.02
After Hours:
11.52
Arcus Biosciences Inc stock is traded at $11.52, with a volume of 711.15K.
It is up +0.17% in the last 24 hours and up +19.13% over the past month.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
See More
Previous Close:
$11.50
Open:
$11.5
24h Volume:
711.15K
Relative Volume:
0.81
Market Cap:
$1.23B
Revenue:
$247.00M
Net Income/Loss:
$-249.00M
P/E Ratio:
-3.7282
EPS:
-3.09
Net Cash Flow:
$-267.00M
1W Performance:
-5.50%
1M Performance:
+19.13%
6M Performance:
+18.76%
1Y Performance:
-33.76%
1-Day Range:
$11.44
$11.84
1-Week Range:
$11.04
$12.23
52-Week Range:
$6.50
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
Name
Arcus Biosciences Inc
Sector
Industry
Phone
(510) 694-6200
Address
3928 POINT EDEN WAY, HAYWARD, CA
Compare RCUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
11.52 | 1.25B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Oct-21-24 | Initiated | H.C. Wainwright | Neutral |
| Oct-08-24 | Initiated | Wells Fargo | Overweight |
| Nov-18-22 | Initiated | BofA Securities | Neutral |
| Oct-11-22 | Initiated | Morgan Stanley | Overweight |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Nov-24-20 | Initiated | Berenberg | Buy |
| Nov-23-20 | Initiated | Evercore ISI | Outperform |
| Apr-03-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-04-20 | Initiated | Barclays | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Sep-27-19 | Initiated | Mizuho | Buy |
| May-24-19 | Resumed | Citigroup | Buy |
| Oct-09-18 | Initiated | Wedbush | Outperform |
| Apr-09-18 | Initiated | Citigroup | Buy |
| Apr-09-18 | Initiated | Goldman | Neutral |
| Apr-09-18 | Initiated | Leerink Partners | Outperform |
View All
Arcus Biosciences Inc Stock (RCUS) Latest News
Arcus Biosciences, Inc. $RCUS Shares Acquired by Woodline Partners LP - MarketBeat
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Jacobs Levy Equity Management Inc. Buys 506,853 Shares of Arcus Biosciences, Inc. $RCUS - MarketBeat
Arcus Biosciences, Inc. $RCUS Shares Bought by Granahan Investment Management LLC - MarketBeat
Parkman Healthcare Partners LLC Has $9.54 Million Stock Holdings in Arcus Biosciences, Inc. $RCUS - MarketBeat
Arcus Biosciences (NYSE:RCUS) Stock Price Down 8%Here's Why - MarketBeat
Trexquant Investment LP Has $1.69 Million Stock Holdings in Arcus Biosciences, Inc. $RCUS - MarketBeat
Transcript : Arcus Biosciences, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 08 - MarketScreener
PDT Partners LLC Sells 35,454 Shares of Arcus Biosciences, Inc. $RCUS - MarketBeat
Cutter Capital Management LP Invests $5.75 Million in Arcus Biosciences, Inc. $RCUS - MarketBeat
19,300 Stock Options at $12.19: Arcus Biosciences Awards New Employee Inducement Grants - Stock Titan
RA Capital Management L.P. Acquires New Shares in Arcus Biosciences, Inc. $RCUS - MarketBeat
Arcus Biosciences (NYSE:RCUS) Stock Price Up 8.5%Should You Buy? - MarketBeat
Can Arcus Biosciences Inc. keep up with sector leadersMarket Activity Recap & AI Driven Stock Reports - beatles.ru
What analysts say about Arcus Biosciences Inc. stockJuly 2025 Opening Moves & Smart Investment Allocation Tips - 뉴스영
Is Arcus Biosciences Inc. stock bottoming out2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - Newser
Using Ichimoku Cloud for Arcus Biosciences Inc. technicalsJuly 2025 Earnings & Technical Buy Zone Confirmations - Newser
Arcus Biosciences Inc.’s volatility index tracking explainedLayoff News & Smart Swing Trading Techniques - Newser
Arcus Biosciences, Inc. $RCUS Shares Acquired by Rafferty Asset Management LLC - MarketBeat
Using data filters to optimize entry into Arcus Biosciences Inc.Long Setup & Fast Exit/Entry Strategy Plans - Newser
There's No Escaping Arcus Biosciences, Inc.'s (NYSE:RCUS) Muted Revenues Despite A 28% Share Price Rise - simplywall.st
Is Arcus Biosciences Inc. stock a smart retirement pickWeekly Profit Report & Daily Profit Focused Screening - خودرو بانک
Nuveen LLC Takes $1.04 Million Position in Arcus Biosciences, Inc. $RCUS - MarketBeat
Azoy Alexander, chief accounting officer, sells Arcus Biosciences shares By Investing.com - Investing.com UK
Why Arcus Biosciences Inc. is moving todayWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
What drives Arcus Biosciences Inc.’s stock priceTake Profit & Community Verified Trade Alerts - خودرو بانک
Strategies to average down on Arcus Biosciences Inc.Weekly Investment Summary & Accurate Buy Signal Alerts - Newser
Smart tools for monitoring Arcus Biosciences Inc.’s price actionJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
What to do if you’re stuck in Arcus Biosciences Inc.2025 Top Gainers & Low Risk Entry Point Guides - Newser
What to expect from Arcus Biosciences Inc. in the next 30 daysEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Is Arcus Biosciences Inc. forming a bottoming baseWeekly Earnings Recap & Fast Entry Momentum Alerts - Newser
What recovery options are there for Arcus Biosciences Inc.Quarterly Profit Review & AI Powered Market Trend Analysis - Newser
Candlestick signals on Arcus Biosciences Inc. stock today2025 Price Momentum & Daily Market Momentum Tracking - Newser
Published on: 2025-09-04 03:31:21 - Newser
Russell Investments Group Ltd. Grows Position in Arcus Biosciences, Inc. $RCUS - MarketBeat
Is Arcus Biosciences Inc. in a long term uptrendTrade Risk Assessment & Risk Managed Investment Entry Signals - خودرو بانک
What machine learning models say about Arcus Biosciences Inc.2025 Biggest Moves & Real-Time Volume Triggers - Newser
Sector ETF performance correlation with Arcus Biosciences Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
Transcript : Arcus Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 11 - MarketScreener
Arcus Biosciences shares rise 7.26% intraday after announcing an Investor Event to highlight new data for its HIF-2a inhibitor casdatifan. - AInvest
Will Arcus Biosciences Inc. see short term momentumJuly 2025 Setups & Technical Confirmation Trade Alerts - Newser
Arcus Biosciences Inc. stock trend forecastTrade Signal Summary & High Win Rate Trade Tips - Newser
Leading vs lagging indicators on Arcus Biosciences Inc. performanceQuarterly Profit Report & Real-Time Buy Signal Notifications - Newser
Wellington Management Group LLP Makes New $8.50 Million Investment in Arcus Biosciences, Inc. $RCUS - MarketBeat
Applying Wyckoff theory to Arcus Biosciences Inc. stock2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Arcus Biosciences Inc Stock (RCUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):